Overview

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
To investigates the effects of solifenacin or mirabegron with local estrogen versus combination treatment with solifenacin and mirabegron in women with overactive bladder
Phase:
PHASE4
Details
Lead Sponsor:
Mackay Memorial Hospital
Treatments:
Estrogens, Conjugated (USP)
mirabegron
Solifenacin Succinate